https://andards.com/tags/gene-therapy/ Recent content in gene-therapy on AndArds Hugo -- gohugo.io en-us Sun, 05 Apr 2026 00:33:00 +0000 https://andards.com/posts/ai-and-gene-editing-the-next-decade-of-longevity-biotech/ Sun, 05 Apr 2026 00:33:00 +0000 https://andards.com/posts/ai-and-gene-editing-the-next-decade-of-longevity-biotech/ The quest to extend healthy human lifespan is undergoing a transformation, propelled by the convergence of artificial intelligence (AI) and gene editing technologies. Over the next decade, these fields are poised to redefine what’s possible in longevity biotech, moving beyond theoretical discussions to tangible, therapeutic interventions. https://andards.com/posts/can-we-transfer-animal-longevity-genes-to-humans/ Wed, 21 Jan 2026 02:52:00 +0000 https://andards.com/posts/can-we-transfer-animal-longevity-genes-to-humans/ The idea of transferring genes from long-lived animals to humans to extend our lifespan is a compelling one, often sparking both scientific curiosity and ethical debate. While the concept might sound like science fiction, research into comparative biology and genetic engineering is actively exploring the mechanisms behind animal longevity and the potential for applying these insights to human health. https://andards.com/posts/george-church-and-bioviva-the-2026-reality-of-age-reversal-gene-therapy/ Sat, 10 Jan 2026 07:13:00 +0000 https://andards.com/posts/george-church-and-bioviva-the-2026-reality-of-age-reversal-gene-therapy/ The concept of reversing aging, once confined to science fiction, is now a serious pursuit within the scientific community. At the forefront of this effort are figures like George Church, a pioneering geneticist from Harvard, and companies like BioViva, known for their bold approaches to longevity. https://andards.com/posts/george-churchs-crispr-therapies-are-we-ready-for-human-trials/ Thu, 08 Jan 2026 21:25:00 +0000 https://andards.com/posts/george-churchs-crispr-therapies-are-we-ready-for-human-trials/ The prospect of using CRISPR gene editing to slow, stop, or even reverse aspects of aging is a recurring theme in conversations about longevity. At the forefront of this discussion is George Church, a pioneering geneticist at Harvard Medical School. https://andards.com/posts/can-we-reprogram-cells-without-yamanaka-factors-the-chemical-approach/ Thu, 08 Jan 2026 19:27:00 +0000 https://andards.com/posts/can-we-reprogram-cells-without-yamanaka-factors-the-chemical-approach/ Yes, it is increasingly possible to reprogram cells without relying on the traditional Yamanaka factors. This alternative, known as chemical cellular reprogramming, uses small molecules to induce changes in cell identity and function. This approach offers distinct advantages over genetic methods, particularly in its potential for greater control, safety, and scalability, moving us closer to therapies that could address aging and various diseases. https://andards.com/posts/george-churchs-vision-for-2026-when-will-gene-therapy-be-available/ Fri, 02 Jan 2026 22:44:00 +0000 https://andards.com/posts/george-churchs-vision-for-2026-when-will-gene-therapy-be-available/ George Church, a prominent figure in genetics and synthetic biology, has consistently pushed the boundaries of what’s considered possible in genetic engineering. When considering a “George Church gene therapy timeline,” particularly for a year like 2026, it’s important to understand that his vision often outpaces immediate clinical availability.